Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has issued an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited held its Annual General Meeting for the financial year ending December 31, 2024, on May 15, 2025. The meeting was conducted both in-person in Tianjin, China, and via video conferencing in Singapore, allowing participation from both A-Share and S-Share shareholders. The AGM was chaired by Ms. Wang Lei, and voting was conducted through a combination of on-site and online methods. This meeting underscores the company’s commitment to engaging with its shareholders across different regions, reflecting its operational transparency and adaptability.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
See more insights into 2TZ stock on TipRanks’ Stock Analysis page.